Australasian Society of Infectious Diseases updated guidelines for the management of Clostridioides difficile infection in adults and children in Australia and New Zealand
Internal Medicine Journal · 2025
DOI: 10.1111/imj.16638 ↗Kurz gefasst
Leitlinie in der Zeitschrift Internal Medicine Journal, 2025. Verfasst von Anthony Longhitano und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Barwon Health, Geelong, Victoria, Australia. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Clostridioides difficile, Clostridium Infections, Disease Management. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Clostridioides difficile infection (CDI) is associated with significant morbidity and mortality within the Australian population. Treatment recommendations for CDI pose challenges at both community and hospital‐based levels due to the recurrent, refractory and potentially severe nature of the disease. Since the last published Australasian guidelines in 2016, new therapeutic options are available, prompting a necessary update to management recommendations. On behalf of the Australasian Society of Infectious Diseases, we present the updated guidelines for the management of CDI in adults and children exploring the changes to treatment recommendations – including the replacement of oral metronidazole with vancomycin for initial CDI and the emerging role for fidaxomicin and faecal‐microbiota transplant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Barwon Health, Geelong, Victoria, Australia.
- Barwon Health, Barwon Southwest Public Health Unit, Geelong, Victoria, Australia.
- Department of Microbiology, Wellington Southern Community Laboratories, Wellington, New Zealand.
- Department of Infectious Diseases, Perth Children's Hospital, Perth, Western Australia, Australia.
- Department of Microbiology, Sullivan Nicolaides Pathology, Brisbane, Queensland, Australia.
ORCID-Profile: Anthony Longhitano
Zitieren
APA
Longhitano, A., Roder, C., Blackmore, T., Campbell, A., May, M., & Athan, E. (2025). Australasian Society of Infectious Diseases updated guidelines for the management of Clostridioides difficile infection in adults and children in Australia and New Zealand. Internal Medicine Journal. https://doi.org/10.1111/imj.16638
Vancouver
Longhitano A, Roder C, Blackmore T, Campbell A, May M, Athan E. Australasian Society of Infectious Diseases updated guidelines for the management of Clostridioides difficile infection in adults and children in Australia and New Zealand. Internal Medicine Journal. 2025. doi:10.1111/imj.16638
BibTeX
@article{Longhitano2025,
author = {Longhitano, Anthony and Roder, Christine and Blackmore, Tim and Campbell, Anita and May, Meryta and Athan, Eugene},
title = {Australasian Society of Infectious Diseases updated guidelines for the management of Clostridioides difficile infection in adults and children in Australia and New Zealand},
journal = {Internal Medicine Journal},
year = {2025},
doi = {10.1111/imj.16638}
}
EUVIMED